Analyzing a Real Company
Everything in Stage 3 now snaps together into one repeatable walkthrough — read the statements, run the ratios, value the business, demand a margin of safety, and reach a verdict.
🎯 By the end you'll be able to
Run a complete fundamental analysis from a blank page — understand the business, read all three statements, compute the key ratios, judge the moat and management, value it with a DCF and multiples, and turn it all into a clear buy / hold / avoid decision with a margin of safety.
KEY INSIGHTThe one idea to take away
Analyzing a company is a checklist, not a guess. Follow the same six steps every time and you remove emotion, gaps, and luck from the process.
Understand the business → check the financials → judge the moat and management → value it → demand a margin of safety → decide. Same order, every company, forever.
Each of the eight lessons before this one handed you a single tool. This lesson is where you pick them all up at once and walk through a real (well, real-ish) company end to end. By the time you reach the verdict, you'll have a workflow you can copy onto any business you ever look at.
A good analysis doesn't promise certainty — it produces a well-reasoned bet with a margin of safety. You win on average and survive the losses. That's the whole game.
"Meridian Devices, Inc." (ticker: MRDN) is a fictional, illustrative example. The numbers are realistic but invented to teach the method cleanly. Nothing here is investment advice or a view on any real security. Treat the workflow as the lesson; the company is just the worksheet.
FRAMEWORKThe full workflow, on one page
Before we dive into Meridian, here's the map. Six steps, in order. You never skip one, and you rarely change the sequence — qualitative judgement before valuation, valuation before price, price discipline last.
You read the business before the numbers so the numbers mean something. You value it before looking at price so the price can't anchor your estimate. And you save margin-of-safety for last, because price discipline is where most of the protection lives.
STEP 1 · BUSINESSUnderstand how Meridian makes money
Before a single ratio: what does it sell, to whom, and how does cash actually arrive? If you can't explain that simply, stop — that's Buffett's circle of competence. Only invest in what you understand.
Meridian Devices (MRDN) designs and sells specialised industrial sensors — the small, boring components that go inside factory robots, HVAC systems, and medical equipment. Two revenue lines:
- Hardware (62% of revenue) — the sensors themselves, sold to equipment makers (OEMs) on multi-year design wins. Once a customer designs a Meridian sensor into their product, ripping it out is expensive and risky — that's the source of stickiness.
- Software & services (38%) — a calibration/monitoring subscription that rides on top of the hardware. Recurring, high-margin, and growing faster than hardware.
In one paragraph: Meridian sells a cheap-but-critical component, locks it into customers' product designs for years, then layers a recurring software subscription on top. That combination — a sticky, low-cost-of-failure component plus recurring revenue — is exactly the kind of business that can have a moat. Whether it actually does is Step 4's job.
In real life you'd get all of this from the annual report and the MD&A (management discussion & analysis). Read those sections first, every time. They tell you, in management's own words, what drove the year — and where the bodies might be buried.
STEP 2 · STATEMENTSRead the three statements over 5 years
Never judge a company on a single snapshot — you want trends. Here are Meridian's last five fiscal years (figures in millions of USD, illustrative).
The income statement — is it growing profitably?
| Income statement ($M) | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | 820 | 945 | 1,090 | 1,240 | 1,420 |
| Gross profit | 443 | 520 | 611 | 707 | 823 |
| Operating income | 156 | 189 | 229 | 273 | 327 |
| Net income | 115 | 140 | 171 | 205 | 248 |
| EPS ($) | 1.18 | 1.45 | 1.78 | 2.15 | 2.62 |
Revenue compounds at roughly 15% a year; gross margin drifts up from 54% to 58% (the higher-margin software mix at work); net income grows even faster than revenue (16%+). EPS rises every single year. This is the shape you want: growing revenue, stable-to-improving margins, rising EPS.
The balance sheet — could it survive a bad year?
| Balance sheet ($M) | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash & equivalents | 210 | 265 | 340 |
| Total assets | 1,180 | 1,360 | 1,580 |
| Total debt | 260 | 250 | 240 |
| Total equity | 720 | 850 | 1,005 |
| Retained earnings | 540 | 690 | 870 |
Debt is falling while equity and retained earnings climb. Net debt is actually negative (cash $340M > debt $240M) — Meridian could pay off every dollar it owes tomorrow and still have $100M left. A company with net cash and growing retained earnings can absolutely survive a bad year.
The cash flow statement — is the profit real?
| Cash flow ($M) | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income | 171 | 205 | 248 |
| Operating cash flow | 198 | 236 | 288 |
| Capital expenditure | −44 | −51 | −58 |
| Free cash flow | 154 | 185 | 230 |
Operating cash flow ($288M) exceeds net income ($248M) every year, and free cash flow grows right alongside profit. When profit and cash track each other like this, the earnings are real. If they ever diverge, trust the cash.
STEP 3 · RATIOSCompute the diagnostic toolkit
Numbers in isolation mean nothing — every ratio gets compared to peers and to Meridian's own history. Assume the market price is $72 and shares outstanding are 94.5M (so market cap ≈ $6.8B). Here's the diagnostic panel for FY25.
| Ratio | Meridian FY25 | Peer median | Read |
|---|---|---|---|
| Valuation | |||
| P/E | 27.5× | 24× | Slight premium |
| PEG (P/E ÷ growth) | 1.8 | 2.1 | Reasonable |
| EV/EBITDA | 18× | 17× | In line |
| Profitability | |||
| Net margin | 17.5% | 12% | Superior |
| ROE | 24.7% | 15% | Excellent |
| ROIC | 21% | 11% | > cost of capital |
| Health | |||
| Debt / equity | 0.24 | 0.60 | Conservative |
| Interest coverage | 28× | 9× | Very safe |
| Current ratio | 2.4 | 1.6 | Liquid |
Is the high ROE real, or just debt?
A 24.7% ROE could be a great business — or a mediocre one juiced with leverage. The DuPont decomposition splits ROE into its three drivers:
ROE = Net margin × Asset turnover × Equity multiplier
For Meridian: 17.5% × 0.90 × 1.57 = 24.7%. The equity multiplier is just 1.57 (low — barely any leverage), so the high ROE comes from fat margins, not debt. That's the good kind of ROE. A value-trap version would show a high ROE driven by an equity multiplier of 4 or 5.
A cheap P/E with falling revenue, a debt-fuelled ROE, or cash flow that lags profit is a classic value trap — cheap for a reason. Meridian shows none of these signs. But you only know that because you checked.
STEP 4 · QUALITATIVEJudge the moat and management
The numbers tell you the past was good. The moat tells you whether the future will be too. Does Meridian have a durable competitive advantage — and is it widening or narrowing?
| Moat source | Present? | Evidence |
|---|---|---|
| Switching costs | Strong | Sensors designed into customers' products for 5–7 yr cycles |
| Recurring revenue | Yes | 38% software/services, >95% retention |
| Pricing power | Moderate | Component is <2% of customer's cost but mission-critical |
| Network / scale | Limited | Some R&D scale; not a network business |
| Brand / patents | Yes | Patent portfolio on calibration tech |
Pricing power is the tell. Because a Meridian sensor is a tiny fraction of the customer's total product cost but a huge source of risk if it fails, customers will pay up and won't switch over a few percent. That's a real, if not enormous, moat — and the rising gross margin suggests it's widening, not narrowing.
Management & capital allocation
- Honest? Past guidance has matched results within a few percent; no restatements; plain-English reporting. Good signs.
- Good capital allocator? ROIC of 21% on reinvested cash, modest buybacks below intrinsic value, no empire-building acquisitions. They reinvest where returns are high and return the rest.
- Governance red flags? None obvious — independent board majority, reasonable pay, no related-party dealing.
Industry structure matters: high switching costs blunt rivalry, the mission-critical role weakens buyer power, and the patent moat raises the barrier to new entrants. The runway — factory automation and medical devices — is still growing. Structurally favourable.
STEP 5 · VALUATIONTwo independent estimates of intrinsic value
Never trust one valuation method. Build a range from at least two — here, a discounted cash flow and a peer-multiple sanity check.
Method A — a simple DCF
We discount Meridian's future free cash flow back to today. The inputs (all illustrative):
| DCF input | Value | Why |
|---|---|---|
| Starting FCF (FY25) | $230M | From the cash flow statement |
| Growth, years 1–5 | 12% | Below recent 15% — conservative |
| Growth, years 6–10 | 6% | Maturing |
| Terminal growth | 3% | ≈ long-run GDP |
| Discount rate (WACC) | 9% | Low-debt, stable business |
Sum the discounted ten years of FCF plus a discounted terminal value, divide by 94.5M shares, and the base case lands near $84 per share. Because a DCF is exquisitely sensitive to its assumptions, you run a sensitivity analysis rather than trusting one number:
| Per-share DCF | WACC 8% | WACC 9% | WACC 10% |
|---|---|---|---|
| Growth 14% | $102 | $91 | $82 |
| Growth 12% | $94 | $84 | $76 |
| Growth 10% | $86 | $78 | $71 |
The DCF range is roughly $71–$102, clustered around the low-to-mid $80s.
Method B — peer multiples
A cross-check using what the market pays for similar businesses. Meridian deserves a slight premium for its higher margins and net-cash balance sheet:
- Apply a 26× P/E (peer median 24×, plus a quality premium) to FY26 EPS of ~$3.05 → ≈ $79.
- Apply an 18× EV/EBITDA to FY25 EBITDA, add net cash, ÷ shares → ≈ $83.
DCF center (~$84), P/E (~$79), EV/EBITDA (~$83). Three independent methods landing in the high-$70s to mid-$80s is far more convincing than any single point estimate. Call fair value ≈ $80 (range $74–$88).
STEP 6 · DECISIONApply a margin of safety and decide
Now — and only now — we compare price to value. Meridian trades at $72; our fair-value estimate is ≈ $80.
The margin of safety is the gap between price and value, expressed as a discount: ($80 − $72) ÷ $80 = 10%. The stock is cheap relative to our estimate — but only modestly.
For a stable, high-quality, net-cash compounder, many investors accept a smaller margin of safety (10–15%) than they'd demand for a fragile or cyclical business (30%+). A 10% discount on a great business is a reasonable — not screaming — entry. A disciplined verdict here is a cautious BUY, or a HOLD with a buy order set lower (say below $68, a 15% margin).
Notice what discipline buys you: if the price were $95 (above fair value), the verdict flips to AVOID / WATCH no matter how wonderful the business — you'd add it to a watchlist and wait. Great company, wrong price, is still a pass.
SEE ITThe company scorecard
Here's Meridian's whole analysis on one dashboard — the vital signs up top, the revenue/earnings trend in the middle, and a live intrinsic-value verdict at the bottom. Nudge the growth and discount-rate sliders and watch the verdict flip.
EXAMPLETwo worked cases: US and Indonesia
The six steps are universal. What changes between markets is the context layer you bolt on at the end. Compare a US large-cap with an IDX blue-chip bank.
Our Meridian walkthrough is the US case: a dollar-reporting large-cap with a clear moat, a clean balance sheet, and a DCF-plus-multiples valuation. The headline numbers, recapped:
| Meridian (MRDN) · illustrative | Value |
|---|---|
| Revenue (FY25) | $1,420M |
| Net income | $248M |
| ROE · ROIC | 24.7% · 21% |
| Fair value range | $74–$88 |
| Price · verdict | $72 · cautious BUY |
US-specific checks are light: deep, liquid markets; standardised filings (10-K, 10-Q); a 15–20% long-term capital-gains tax rather than a transaction tax. The main risk is simply paying too much for a beloved quality name.
Now an Indonesian blue-chip — a large, well-run private bank in the mould of the big IDX names (call it "Bank Nusantara," a fictional BBCA-style lender). Same six steps, different vital signs and an extra context layer. Figures in trillions of Rupiah, illustrative.
| Bank Nusantara · illustrative | Value | Bank-specific read |
|---|---|---|
| Net interest income (FY25) | Rp 78T | Core earnings engine |
| Net profit | Rp 54T | Steady double-digit growth |
| Net interest margin (NIM) | 5.6% | High — cheap deposits |
| ROE | 21% | Best-in-class for a bank |
| Non-performing loans | 1.8% | Low — clean book |
| CASA ratio | 82% | Sticky, low-cost funding |
| P/E · P/B | 21× · 4.2× | Premium for quality |
For a bank, you swap a few tools: a DCF on free cash flow is awkward, so you value on P/B relative to ROE and a dividend-discount model instead. A bank earning a 21% ROE rightly trades at a higher price-to-book than one earning 10%. NIM, NPLs, and the CASA (low-cost deposit) ratio replace gross margin as the vital signs.
Add four local checks: governance & ownership concentration (who really controls the company?), currency exposure (Rupiah weakness hits foreign-funded firms), rate & commodity sensitivity (the economy moves with global rates and coal/palm-oil cycles), and the ~0.1% final transaction tax on every sale. The framework is identical; the context differs.
PRACTICALForce yourself to write the thesis
The discipline that exposes weak reasoning is writing it down — one page, before you buy. Here's Meridian's, compressed:
- Business: sticky industrial-sensor maker with a growing high-margin software layer; net cash; 15% grower.
- Bull case: software mix keeps lifting margins, switching costs hold, factory-automation runway compounds for a decade.
- Bear case: a customer designs out the sensor, a price war erodes the moat, or growth slows and the 27× P/E compresses.
- Valuation: fair value ≈ $80 (range $74–$88); I'd buy comfortably below $68 (15% margin of safety).
- Catalysts: software crossing 45% of revenue; a major new design win; margin guidance raised.
- Sell triggers: two straight quarters of margin decline, a major customer loss, or net debt turning positive. Pre-committed.
- Decision: cautious BUY at $72; full position below $68. Watch, don't chase.
A thesis you can revisit is also how you learn: months later you compare what happened to what you predicted, and your judgement improves. Verbal convictions evaporate; written ones get graded.
WEAKNESSCommon mistakes to avoid
A wonderful company at a terrible price is a bad investment. The verdict can — and should — be "great company, AVOID for now."
A DCF is a sensitivity machine, not an oracle. Always produce a range, and cross-check with multiples. If two methods wildly disagree, find out why before you act.
A single great year can be a fluke or accounting noise. Trends over 3–5 years reveal whether margins, cash flow, and growth are durable.
Earnings can be massaged; cash is harder to fake. If operating cash flow chronically lags net income, something is off — trust the cash.
Ratios describe the past. Only the moat and management tell you whether the past repeats. Numbers without a moat assessment is half an analysis.
PRACTICALYour reusable analytical checklist
Copy this onto every company you ever look at. Ten boxes; tick them honestly.
| # | Check | Meridian |
|---|---|---|
| 1 | I understand how this business makes money | ✓ |
| 2 | Revenue, margins, EPS trending well over 3–5 yrs | ✓ |
| 3 | Balance sheet strong; debt manageable | ✓ (net cash) |
| 4 | Operating cash flow & FCF healthy, tracking profit | ✓ |
| 5 | Ratios solid vs peers & history; no value-trap signs | ✓ |
| 6 | Durable, ideally widening moat; pricing power | ✓ |
| 7 | Trustworthy management; good capital allocation | ✓ |
| 8 | Intrinsic value estimated (2 methods, as a range) | ✓ |
| 9 | Price offers a margin of safety | ~ (only 10%) |
| 10 | Written thesis with bull/bear, risks, sell triggers | ✓ |
Nine clean ticks and one "almost" — the only soft spot is price. That's exactly the situation where you set a limit order below the market and let discipline, not impatience, decide.
GLOSSARYKey terms introduced
- Circle of competence
- Investing only in businesses you genuinely understand.
- Investment thesis
- Your written bull/bear case, valuation, and decision, on one page.
- Margin of safety
- The discount of price below your estimated intrinsic value.
- Catalyst
- An event that may cause the market to recognise hidden value.
- Watchlist
- Good businesses awaiting a good price.
- Sell trigger
- A pre-defined condition that tells you to exit.
- DuPont analysis
- Splits ROE into margin × turnover × leverage to find its true driver.
- Sensitivity analysis
- Re-running a valuation across a grid of assumptions to get a range.
ACTIVE RECALLCheck your understanding
Answer in your own words first, then reveal. If you can say it out loud, you own it.
1List the six steps of the full analysis workflow, in order.›
① Understand the business → ② Read the three statements (3–5 yr trends) → ③ Compute key ratios vs peers and history → ④ Assess moat & management → ⑤ Value it (DCF + multiples, as a range) → ⑥ Apply a margin of safety and decide.
2Why look at 3–5 years of statements rather than just the latest year?›
One year can be a fluke, a cyclical peak, or accounting noise. Trends over several years reveal whether revenue growth, margins, and cash flow are durable — and let you spot a deteriorating business (a value trap) before the single-year numbers admit it.
3What belongs in a written investment thesis — and why bother writing it down?›
Business in a paragraph, bull case, bear case, valuation/fair-value range, catalysts, key risks, and pre-committed sell triggers, ending in a decision. Writing it down exposes weak reasoning you'd otherwise skate over, and gives you something to grade later — comparing what happened to what you predicted is how judgement improves.
4Why is the goal "good bets with a margin of safety," not certainty?›
You'll never have complete information, and the future is genuinely uncertain — even a perfect analysis can be wrong. The realistic aim is to make well-reasoned bets at prices that protect you when you're wrong, repeatedly, so you win on average and survive the losses. The margin of safety is that protection.